Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Gilead-Sciences
Company Monitoring Page for Gilead-Sciences
latest headlines for company on cafepharma
Gilead's Tecartus gets revised safety demand amid FDA's push for CAR-T boxed warnings
Fierce Pharma
Wed, 01/24/24 - 10:46 am
Tags:
Gilead Sciences
,
Tecartus
,
CAR-T
,
FDA
FDA requires 'boxed warning' for CAR-T cancer therapies
Reuters
Mon, 01/22/24 - 10:10 pm
Tags:
CAR-T
,
FDA
,
warnings
,
Gilead Sciences
,
JNJ
,
Novartis
Gilead's Trodelvy fails to extend survival in lung cancer study, prompting selloff
Fierce Pharma
Mon, 01/22/24 - 11:21 am
Tags:
Gilead Sciences
,
antibody-drug conjugate
,
Trodelvy
,
lung cancer
,
clinical trials
Gilead calls off Oceanside manufacturing expansion, uproots biologics development team
Fierce Pharma
Wed, 01/17/24 - 08:45 pm
Tags:
Gilead Sciences
,
biologics
,
California
,
drug manufacturing
CAR-T hype faces infrastructure reality check
Fierce Pharma
Tue, 01/16/24 - 09:22 am
Tags:
CAR-T
,
cell therapy
,
gene therapy
,
Gilead Sciences
,
JNJ
Gilead Sciences Must Face Consumer Claims Over Older, Lower-Quality Drugs, Court Rules
BioSpace
Fri, 01/12/24 - 11:34 am
Tags:
Gilead Sciences
,
legal
,
HUV
10 clinical trials to watch in the first half of 2024
BioPharma Dive
Wed, 01/3/24 - 05:08 pm
Tags:
clinical trials
,
Beam Therapeutics
,
Moderna Therapeutics
,
Pfizer
,
Sanofi
,
Gilead Sciences
,
JNJ
,
Amylx
,
Roche
,
Alnylam Pharmaceuticals
,
Vertex Pharmaceuticals
Gilead downloads solid tumor program from Compugen for $60M upfront
Fierce Biotech
Tue, 12/19/23 - 10:05 am
Tags:
Gilead Sciences
,
CompuGen
,
solid tumors
Gilead cuts 7% of staff at Kite Pharma unit as 'refreshed business strategy' introduced
Fierce Pharma
Wed, 11/29/23 - 11:55 am
Tags:
Kite Pharma
,
Gilead Sciences
,
layoffs
Gilead’s Kite Expands Arcellx Pact with $285M Equity Investment, Upfront Cash
BioSpace
Wed, 11/15/23 - 11:11 am
Tags:
Gilead Sciences
,
Kite Pharma
,
Arcellx
,
CART-ddBCMA
,
lymphoma
Gilead Tumbles After An Unpredictable Element Drove Its Third-Quarter Beat
Investors Business Daily
Wed, 11/8/23 - 11:39 am
Tags:
Gilead Sciences
,
earnings
,
Veklury
Gilead Sciences and Arcus Biosciences report cancer trial data
Clinical Trials Arena
Tue, 11/7/23 - 09:46 am
Tags:
Gilead Sciences
,
Arcus Biosciences
,
domvanalimab
,
zimberelimab
,
upper GI cancers
,
clinical trials
Merck KGaA pays $169M for selective PARP1 drug, stepping up challenge to AstraZeneca and Gilead
Fierce Biotech
Mon, 10/30/23 - 11:58 am
Tags:
Merck KGaA
,
PARP inhibitors
,
Lynparza
,
Zejula
,
AstraZeneca
,
Gilead Sciences
,
solid tumors
Gilead plans European trial of twice-yearly HIV PrEP drug
Pharmaphorum
Wed, 10/18/23 - 10:08 am
Tags:
Gilead Sciences
,
clinical trials
,
HIV
,
PrEP
,
Sunlenca
,
Europe
Gilead pays $100M for first dibs on all Assembly Bio assets, bolting antiviral engine to its R&D group
Fierce Biotech
Tue, 10/17/23 - 10:27 am
Tags:
Gilead Sciences
,
Assembly Biosciences
,
antivirals
,
hepatitis B
Gilead Axes Phase III Magrolimab Trial Based on Disappointing Data
BioSpace
Wed, 09/27/23 - 11:12 pm
Tags:
Gilead Sciences
,
magrolimab
,
clinical trials
,
blood cancers
Gilead Sciences, after trial win, moves ahead with $247M settlement in HIV antitrust case
Fierce Pharma
Tue, 09/26/23 - 11:47 am
Tags:
Gilead Sciences
,
Teva Pharmaceutical
,
HIV
,
legal
,
antitrust
Could Gilead’s Trodelvy be the next TROP-2 therapy game-changer in NSCLC treatment?
Clinical Trials Arena
Fri, 09/22/23 - 12:00 pm
Tags:
Gilead Sciences
,
Trodelvy
,
TROP-2
,
non-small cell lung cancer
Kite publishes Phase II data for Yescarta in treating B-cell lymphoma
Clinical Trials Arena
Mon, 09/18/23 - 09:53 am
Tags:
Gilead Sciences
,
Kite Pharma
,
Yescarta
,
clinical trials
,
CAR-T
,
relapsed or refractory large B-cell lymphoma
Gilead unveils promising data from trial of combo therapy for lung cancer
Clinical Trials Arena
Mon, 09/11/23 - 11:55 am
Tags:
Gilead Sciences
,
Trodelvy
,
metastatic non-small cell lung cancer
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.